Infiltrates in protocol biopsies from renal allografts

American Journal of Transplantation

Volumn 7, Issue 2, 2007, Pages 356-365

  Mengel, M ^a   Gwinner, W ^a   Schwarz, A ^a   Bajeski, R ^a   Franz, I ^a   Brocker V ^a   Becker, T ^a   Neipp, M ^a   Klempnauer, J ^a   Haller, H ^a   Kreipe, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Protocol biopsies; Renal transplantation

Indexed keywords

CD20 ANTIBODY; CD68 ANTIGEN; GRANZYME B; PROTEIN KINASE ZAP 70;

ARTICLE; ATROPHIC INFILTRATE; B LYMPHOCYTE; CELL COMPOSITION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIFFUSE INFILTRATE; HISTIOCYTE; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MORPHOLOGY; MULTIFOCAL INFILTRATE; NODULAR INFILTRATE; PRIORITY JOURNAL; RAGGEDLY INFILTRATE; T LYMPHOCYTE; TREATMENT OUTCOME; UNIFOCAL INFILTRATE;

BIOPSY; CLINICAL PROTOCOLS; CREATININE; GRAFT REJECTION; HUMANS; INFLAMMATION; KIDNEY CORTEX; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LINEAR MODELS; PREDICTIVE VALUE OF TESTS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33846243266     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01635.x     Document Type: Article

References (43)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite amarked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
3. Kasiske BL, Gaston RS, Gourishankar S et al. Long-Term deterioration of kidney allograft function. Am J Transplant 2005; 5: 1405-1414.
4. Colvin RB. Chronic allograft nephropathy. N Engl JMed 2003; 349: 2288-2290.
5. Paul LC. Chronic allograft nephropathy: An update. Kidney Int 1999; 56: 783-793.
6. Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9: 2129-2134.
7. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59: 511-514.
8. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients: Repeated inflammation is associated with impaired graft function at 1 year. Transplant Proc 1995; 27: 1017-1018.
9. Schwarz A, Mengel M, Gwinner W et al. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005; 67: 341-348.
10. Seron D, Moreso F, Bover J et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310-316.
11. Seron D, Moreso F. Protocol biopsies and risk factors associated with chronic allograft nephropathy. Transplant Proc 2002; 34: 331-332.
12. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
13. Choi BS, Shin MJ, Shin SJ et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant 2005; 5: 1354-1360.
14. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015-3026.
15. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
16. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
17. Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 1930-1941.
18. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464-2472.
19. Moreso F, Ibernon M, Goma M et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747-752.
20. Schwarz A, Mengel M, Gwinner W et al. Protocol biopsy program after renal transplantation: Structure and first results. Transplant Proc 2002; 34: 2238-2239.
21. Schwarz A, Gwinner W, Hiss M, Radermacher J, Mengel M, Haller H. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 2005; 5: 1992-1996.
22. Gwinner W, Suppa S, Mengel M et al. Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 2005; 5: 1934-1941.
23. Solez K. International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin Transplant 1994; 8: 345-350.
24. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
25. Solez K, Hansen HE, Kornerup HJ et al. Clinical validation and reproducibility of the Banff schema for renal allograft pathology. Transplant Proc 1995; 27: 1009-1011.
26. Einecke G, Melk A, Ramassar V et al. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am J Transplant 2005; 5: 1827-1836.
27. Hippen BE, DeMattos A, Cook WJ, Kew CE, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 2248-2252.
28. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
29. Alausa M, Almagro U, Siddiqi N, Zuiderweg R, Medipalli R, Hariharan S. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Clin Transplant 2005; 19: 137-140.
30. Townsend SE, Goodnow CC. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J Exp Med 1998; 187: 1611-1621.
31. Steinmetz OM, Panzer U, Kneissler U et al. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005; 67: 1616-1621.
32. Rivera A, Chen CC, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: Antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 2001; 13: 1583-1593.
33. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612.
34. Fu YX, Chaplin DD. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999; 17: 399-433.
35. Constant SL. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 1999; 162: 5695-5703.
36. Chan O, Shlomchik MJ. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 1998; 160: 51-59.
37. Bhogal RK, Bona CA. B cells: No longer bystanders in liver fibrosis. J Clin Invest 2005; 115: 2962-2965.
38. Novobrantseva TI, Majeau GR, Amatucci A et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005; 115: 3072-3082.
39. Lehnhardt A, Mengel M, Pape L, Ehrich JH, Offner G, Strehlau J. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab. Am J Transplant 2006; 6: 847-851.
40. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Delta analysis of posttransplantation tubulointerstitial damage. Transplantation 2004; 78: 434-441.
41. Shishido S, Asanuma H, Nakai H, Mori Y, Satoh H, Kamimaki I et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046-1052.
42. Einecke G, Fairhead T, Hidalgo LG et al. Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B. Am J Transplant 2006; 6: 2104-2120.
43. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181.